Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Condition:   Non Alcoholic Steatohepatitis Interventions:   Drug: Pioglitazone 30mg;   Drug: Empagliflozin 10 MG Sponsor:   Tanta University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials